{"transactions":[{"id":1024730,"issuer":{"id":608,"kind":"organization","name":"Outlook Therapeutics, Inc.","symbol":"OTLK"},"owners":[{"id":74560,"kind":"person","name":"Huang Andong","position":1,"cik":"0001815678","reported_name":"Huang Andong","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-10-03T20:37:02.000Z","date":"2025-10-03","kind":"grant","planned":false,"acquired":true,"shares":53316,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options were granted under the 2024 Plan in lieu of $50,000 cash fees payable under the Issuer's Non-Employee Director Compensation Policy and vest in four equal quarterly installments on the last day of each fiscal quarter such that they are vested in full on September 30, 2026, subject to the Reporting Person providing continuous service to the Issuer on such date and subject to acceleration upon a Change in Control as defined in the 2024 Plan, subject to the Reporting Person providing continuous service to the Issuer immediately prior to such Change in Control."}],"balance_after":53316,"derivative":{"exercise_price":1.06,"expiration_date":"2035-10-03","underlying":"Common Stock","underlying_shares":53316},"source":{"system":"sec-edgar","filing":"0001649989-25-000010","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1815678/000164998925000010/primary_doc.xml","form_type":"4"}},{"id":1024729,"issuer":{"id":608,"kind":"organization","name":"Outlook Therapeutics, Inc.","symbol":"OTLK"},"owners":[{"id":74560,"kind":"person","name":"Huang Andong","position":1,"cik":"0001815678","reported_name":"Huang Andong","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-10-03T20:37:02.000Z","date":"2025-10-01","kind":"grant","planned":false,"acquired":true,"shares":286734,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option grant is an annual stock option grant under the Issuer's Non-Employee Director Compensation Policy and the Issuer's 2024 Equity Incentive Plan (the \"2024 Plan\") and shall fully vest on October 1, 2026, subject to the Reporting Person providing continuous service to the Issuer on such date. In addition, the shares underlying the options are subject to acceleration upon a Change in Control as defined in the 2024 Plan, subject to the Reporting Person providing continuous service to the Issuer immediately prior to such Change in Control."}],"balance_after":286734,"derivative":{"exercise_price":1.04,"expiration_date":"2035-10-01","underlying":"Common Stock","underlying_shares":286734},"source":{"system":"sec-edgar","filing":"0001649989-25-000010","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1815678/000164998925000010/primary_doc.xml","form_type":"4"}},{"id":1392179,"issuer":{"id":608,"kind":"organization","name":"Outlook Therapeutics, Inc.","symbol":"OTLK"},"owners":[{"id":74560,"kind":"person","name":"Huang Andong","position":1,"cik":"0001815678","reported_name":"Huang Andong","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-10-03T20:30:16.000Z","date":"2024-10-03","kind":"grant","planned":false,"acquired":true,"shares":10984,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The options were granted under the 2024 Plan in lieu of $50,000 cash fees payable under the Issuer's Non-Employee Director Compensation Policy and vest in four equal quarterly installments on the last day of each fiscal quarter such that they are vested in full on September 30, 2025, subject to the Reporting Person providing continuous service to the Issuer on such date and subject to acceleration upon a Change in Control as defined in the 2024 Plan, subject to the Reporting Person providing continuous service to the Issuer immediately prior to such Change in Control."}],"balance_after":10984,"derivative":{"exercise_price":5.25,"expiration_date":"2034-10-03","underlying":"Common Stock","underlying_shares":10984},"source":{"system":"sec-edgar","filing":"0001415889-24-024707","document":"form4-10032024_081013.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1815678/000141588924024707/form4-10032024_081013.xml","form_type":"4"}},{"id":1392178,"issuer":{"id":608,"kind":"organization","name":"Outlook Therapeutics, Inc.","symbol":"OTLK"},"owners":[{"id":74560,"kind":"person","name":"Huang Andong","position":1,"cik":"0001815678","reported_name":"Huang Andong","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-10-03T20:30:16.000Z","date":"2024-10-01","kind":"grant","planned":false,"acquired":true,"shares":23509,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option grant was made under the 2024 Plan and shall fully vest on October 1, 2025, subject to the Reporting Person providing continuous service to the Issuer on such date. In addition, the shares underlying the options are subject to acceleration upon a Change in Control as defined in the 2024 Plan, subject to the Reporting Person providing continuous service to the Issuer immediately prior to such Change in Control."}],"balance_after":23509,"derivative":{"exercise_price":5.22,"expiration_date":"2034-10-01","underlying":"Common Stock","underlying_shares":23509},"source":{"system":"sec-edgar","filing":"0001415889-24-024707","document":"form4-10032024_081013.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1815678/000141588924024707/form4-10032024_081013.xml","form_type":"4"}},{"id":1392177,"issuer":{"id":608,"kind":"organization","name":"Outlook Therapeutics, Inc.","symbol":"OTLK"},"owners":[{"id":74560,"kind":"person","name":"Huang Andong","position":1,"cik":"0001815678","reported_name":"Huang Andong","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-10-03T20:30:16.000Z","date":"2024-10-01","kind":"grant","planned":false,"acquired":true,"shares":56636,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option grant is an annual stock option grant under the Issuer's Non-Employee Director Compensation Policy and the Issuer's 2024 Equity Incentive Plan (the \"2024 Plan\") and shall fully vest on October 1, 2025, subject to the Reporting Person providing continuous service to the Issuer on such date. In addition, the shares underlying the options are subject to acceleration upon a Change in Control as defined in the 2024 Plan, subject to the Reporting Person providing continuous service to the Issuer immediately prior to such Change in Control."}],"balance_after":56636,"derivative":{"exercise_price":5.22,"expiration_date":"2034-10-01","underlying":"Common Stock","underlying_shares":56636},"source":{"system":"sec-edgar","filing":"0001415889-24-024707","document":"form4-10032024_081013.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1815678/000141588924024707/form4-10032024_081013.xml","form_type":"4"}},{"id":1586970,"issuer":{"id":608,"kind":"organization","name":"Outlook Therapeutics, Inc.","symbol":"OTLK"},"owners":[{"id":74560,"kind":"person","name":"Huang Andong","position":1,"cik":"0001815678","reported_name":"Huang Andong","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-03-08T16:18:39.000Z","date":"2024-03-07","kind":"grant","planned":false,"acquired":true,"shares":94441,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options were granted under the Issuer's 2015 Equity Incentive Plan (the \"2015 Plan\") and shall fully vest on the earlier of (i) March 7, 2025; or (ii) the date of the Issuer's next annual meeting of stockholders, in each case subject to the Reporting Person providing continuous service to the Issuer on such date. In addition, the shares underlying the options are subject to acceleration upon a Change in Control as defined in the 2015 Plan, subject to the Reporting Person providing continuous service to the Issuer immediately prior to such Change in Control."}],"balance_after":94441,"derivative":{"exercise_price":0.41,"expiration_date":"2034-03-07","underlying":"Common Stock","underlying_shares":94441},"source":{"system":"sec-edgar","filing":"0001415889-24-007342","document":"form4-03082024_090327.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1815678/000141588924007342/form4-03082024_090327.xml","form_type":"4"}},{"id":1764368,"issuer":{"id":608,"kind":"organization","name":"Outlook Therapeutics, Inc.","symbol":"OTLK"},"owners":[{"id":74560,"kind":"person","name":"Huang Andong","position":1,"cik":"0001815678","reported_name":"Huang Andong","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-10-05T17:14:47.000Z","date":"2023-10-04","kind":"grant","planned":false,"acquired":true,"shares":191113,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options were granted under the 2015 Plan in lieu of $40,000 cash fees payable under the Issuer's non-employee Director compensation program and vest in four equal quarterly installments on the last day of each fiscal quarter such that they are vested in full on September 30, 2024, subject to the Reporting Person providing continuous service to the Issuer on such date and subject to acceleration upon a Change in Control as defined in the 2015 Plan."}],"balance_after":191113,"derivative":{"exercise_price":0.24,"expiration_date":"2033-10-04","underlying":"Common Stock","underlying_shares":191113},"source":{"system":"sec-edgar","filing":"0001209191-23-052239","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1815678/000120919123052239/doc4.xml","form_type":"4"}},{"id":1934075,"issuer":{"id":608,"kind":"organization","name":"Outlook Therapeutics, Inc.","symbol":"OTLK"},"owners":[{"id":74560,"kind":"person","name":"Huang Andong","position":1,"cik":"0001815678","reported_name":"Huang Andong","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-03-31T17:48:51.000Z","date":"2023-03-29","kind":"grant","planned":false,"acquired":true,"shares":41065,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options were granted under the Issuer's 2015 Equity Incentive Plan (the \"2015 Plan\") and shall fully vest on the earlier of (i) March 29,2024; or (ii) the date of the Issuer's next annual meeting of stockholders, in each case subject to the Reporting Person providing continuous service to the Issuer on such date. In addition, the shares underlying the options are subject to acceleration upon a Change in Control as defined in the 2015 Plan, subject to the Reporting Person providing continuous service to the Issuer immediately prior to such Change in Control."}],"balance_after":41065,"derivative":{"exercise_price":1.05,"expiration_date":"2033-03-29","underlying":"Common Stock","underlying_shares":41065},"source":{"system":"sec-edgar","filing":"0001209191-23-021910","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1815678/000120919123021910/doc4.xml","form_type":"4"}},{"id":2140518,"issuer":{"id":608,"kind":"organization","name":"Outlook Therapeutics, Inc.","symbol":"OTLK"},"owners":[{"id":74560,"kind":"person","name":"Huang Andong","position":1,"cik":"0001815678","reported_name":"Huang Andong","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-10-07T16:31:59.000Z","date":"2022-10-05","kind":"grant","acquired":true,"shares":38399,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options were granted under the 2015 Plan in lieu of $40,000 cash fees payable under the Issuer's non-employee Director compensation program and vest in four equal quarterly installments on the last day of each fiscal quarter such that they are vested in full on September 30, 2023, subject to the Reporting Person providing continuous service to the Issuer on such date and subject to acceleration upon a Change in Control as defined in the 2015 Plan."}],"balance_after":38399,"derivative":{"exercise_price":1.25,"expiration_date":"2032-10-05","underlying":"Common Stock","underlying_shares":38399},"source":{"system":"sec-edgar","filing":"0001209191-22-053111","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1815678/000120919122053111/doc4.xml","form_type":"4"}},{"id":2319054,"issuer":{"id":608,"kind":"organization","name":"Outlook Therapeutics, Inc.","symbol":"OTLK"},"owners":[{"id":74560,"kind":"person","name":"Huang Andong","position":1,"cik":"0001815678","reported_name":"Huang Andong","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-03-24T17:37:42.000Z","date":"2022-03-23","kind":"grant","acquired":true,"shares":21878,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options were granted under the Issuer's 2015 Equity Incentive Plan (the \"2015 Plan\") and shall fully vest on the earlier of (i) March 23,2023; or (ii) the date of the Issuer's next annual meeting of stockholders, in each case subject to the Reporting Person providing continuous service to the Issuer on such date. In addition, the shares underlying the options are subject to acceleration upon a Change in Control as defined in the 2015 Plan, subject to the Reporting Person providing continuous service to the Issuer immediately prior to such Change in Control."}],"balance_after":21878,"derivative":{"exercise_price":1.92,"expiration_date":"2032-03-23","underlying":"Common Stock","underlying_shares":21878},"source":{"system":"sec-edgar","filing":"0001209191-22-020950","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1815678/000120919122020950/doc4.xml","form_type":"4"}},{"id":2546498,"issuer":{"id":608,"kind":"organization","name":"Outlook Therapeutics, Inc.","symbol":"OTLK"},"owners":[{"id":74560,"kind":"person","name":"Huang Andong","position":1,"cik":"0001815678","reported_name":"Huang Andong","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-10-07T17:09:58.000Z","date":"2021-10-05","kind":"grant","acquired":true,"shares":22950,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options were granted under the 2015 Plan in lieu of $40,000 cash fees payable under the Issuer's non-employee Director compensation program and vest in four equal quarterly installments on the last day of each fiscal quarter such that they are vested in full on September 30, 2022, subject to the Reporting Person providing continuous service to the Issuer on such date and subject to acceleration upon a Change in Control as defined in the 2015 Plan."}],"balance_after":22950,"derivative":{"exercise_price":2.12,"expiration_date":"2031-10-05","underlying":"Common Stock","underlying_shares":22950},"source":{"system":"sec-edgar","filing":"0001209191-21-059954","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1815678/000120919121059954/doc4.xml","form_type":"4"}},{"id":2770751,"issuer":{"id":608,"kind":"organization","name":"Outlook Therapeutics, Inc.","symbol":"OTLK"},"owners":[{"id":74560,"kind":"person","name":"Huang Andong","position":1,"cik":"0001815678","reported_name":"Huang Andong","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-03-26T18:10:37.000Z","date":"2021-03-24","kind":"grant","acquired":true,"shares":20873,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options were granted under the Issuer's 2015 Equity Incentive Plan (the \"2015 Plan\") and shall vest in full on March 24, 2022, subject to the Reporting Person providing continuous service to the Issuer on such date and subject to acceleration upon a Change in Control as defined in the 2015 Plan, subject to the Reporting Person providing continuous service to the Issuer through such event."}],"balance_after":20873,"derivative":{"exercise_price":2.27,"expiration_date":"2031-03-24","underlying":"Common Stock","underlying_shares":20873},"source":{"system":"sec-edgar","filing":"0001209191-21-023288","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1815678/000120919121023288/doc4.xml","form_type":"4"}},{"id":3013645,"issuer":{"id":608,"kind":"organization","name":"Outlook Therapeutics, Inc.","symbol":"OTLK"},"owners":[{"id":74560,"kind":"person","name":"Huang Andong","position":1,"cik":"0001815678","reported_name":"Huang Andong","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-10-05T18:45:18.000Z","date":"2020-10-05","kind":"grant","acquired":true,"shares":77805,"price":0.5141,"value":39999.5505,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options were granted under the 2015 Plan in lieu of $40,000 cash fees payable under the Issuer's non-employee Director compensation program and vest in four equal quarterly installments on the last day of each fiscal quarter such that they are vested in full on September 30, 2021, subject to the Reporting Person providing continuous service to the Issuer on such date and subject to acceleration upon a Change in Control as defined in the 2015 Plan."}],"balance_after":77805,"derivative":{"exercise_price":0.7052,"expiration_date":"2030-10-05","underlying":"Common Stock","underlying_shares":77805},"source":{"system":"sec-edgar","filing":"0001209191-20-053871","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1815678/000120919120053871/doc4.xml","form_type":"4"}},{"id":3078953,"issuer":{"id":608,"kind":"organization","name":"Outlook Therapeutics, Inc.","symbol":"OTLK"},"owners":[{"id":74560,"kind":"person","name":"Huang Andong","position":1,"cik":"0001815678","reported_name":"Huang Andong","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-07-21T18:08:42.000Z","date":"2020-07-17","kind":"grant","acquired":true,"shares":125000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options were granted under the Issuer's 2015 Equity Incentive Plan (the \"2015 Plan\") and shall vest in full on July 17, 2021, subject to the\nReporting Person providing continuous service to the Issuer on such date and subject to acceleration upon a Change in Control as defined in the 2015 Plan, subject to the Reporting Person providing continuous service to the Issuer through such event."}],"balance_after":125000,"derivative":{"exercise_price":1.58,"expiration_date":"2030-07-17","underlying":"Common Stock","underlying_shares":125000},"source":{"system":"sec-edgar","filing":"0001209191-20-043223","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1815678/000120919120043223/doc4.xml","form_type":"4"}},{"id":3089133,"issuer":{"id":608,"kind":"organization","name":"Outlook Therapeutics, Inc.","symbol":"OTLK"},"owners":[{"id":74560,"kind":"person","name":"Huang Andong","position":1,"cik":"0001815678","reported_name":"Huang Andong","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-07-06T20:00:57.000Z","date":"2020-07-01","kind":"grant","acquired":true,"shares":11376,"price":0.9853,"value":11208.7728,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options were granted under the Issuer's 2015 Equity Incentive Plan (the \"2015 Plan\") in lieu of $11,208.79 cash fees payable under the Issuer's non-employee Director compensation program and vest on the last day of the remaining fiscal quarter such that they are vested in full on September 30, 2020, subject to the Reporting Person providing continuous service to the Issuer on such date and subject to acceleration upon a Change in Control as defined in the 2015 Plan."}],"balance_after":11376,"derivative":{"exercise_price":1.28,"expiration_date":"2030-07-01","underlying":"Common Stock","underlying_shares":11376},"source":{"system":"sec-edgar","filing":"0001209191-20-041328","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1815678/000120919120041328/doc4.xml","form_type":"4"}},{"id":3102143,"issuer":{"id":608,"kind":"organization","name":"Outlook Therapeutics, Inc.","symbol":"OTLK"},"owners":[{"id":74560,"kind":"person","name":"Huang Andong","position":1,"cik":"0001815678","reported_name":"Huang Andong","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-06-23T17:59:19.000Z","date":"2020-06-19","kind":"grant","acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option will vest in three equal annual installments such that the stock option will be fully vested as of the third anniversary of the grant date, subject to (x) the Reporting Person's Continuous Service to the Issuer through such vesting date and (y) acceleration upon a Change in Control."}],"balance_after":25000,"derivative":{"exercise_price":1.35,"expiration_date":"2030-06-19","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001209191-20-038577","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1815678/000120919120038577/doc4.xml","form_type":"4"}}]}